Cited 0 times in
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.